Literature DB >> 27595685

Rationale and design of the Improving Care for Cardiovascular Disease in China (CCC) project: A national effort to prompt quality enhancement for acute coronary syndrome.

Yongchen Hao1, Jing Liu1, Jun Liu1, Sidney C Smith2, Yong Huo3, Gregg C Fonarow4, Changsheng Ma5, Junbo Ge6, Kathryn A Taubert7, Louise Morgan8, Yang Guo1, Qian Zhang1, Wei Wang1, Dong Zhao9.   

Abstract

BACKGROUND: A sizeable gap exists between guideline recommendations for treatment of acute coronary syndrome (ACS) and application of these recommendations in clinical practice. The CCC-ACS project is a novel national quality enhancement registry designed to help medical care providers bridge this gap, thereby improving clinical outcomes for ACS patients in China. METHODS AND
RESULTS: The CCC-ACS project uses data collection, analysis, feedback, rapid-cycle improvement, and performance recognition to extend the use of evidence-based guidelines throughout the health care system and improve cardiovascular health. The project was launched in 2014, with 150 centers recruited representing the diversity of care for ACS patients in tertiary hospitals across China. Clinical information for patients with ACS is collected via a Web-based data collecting platform, including patients' demographics, medical history, symptoms on arrival, in-hospital treatment and procedures, in-hospital outcomes, and discharge medications for secondary prevention. Improvement in adherence to guideline recommendations is facilitated through monthly benchmarked hospital quality reports, recognition of hospital quality achievement, and regular webinars. As of April 16, 2016, a total of 35,616 ACS cases have been enrolled.
CONCLUSIONS: The CCC-ACS is a national hospital-based quality improvement program, aiming to increase adherence to ACS guidelines in China and improve patient outcomes.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27595685     DOI: 10.1016/j.ahj.2016.06.005

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  26 in total

1.  Mild renal insufficiency and attributable risk of adverse In-hospital outcomes in patients with Acute Coronary Syndrome from the improving care for Cardiovascular Disease in China (CCC) project.

Authors:  Fengbo Xu; Guoqin Wang; Nan Ye; Weijing Bian; Lijiao Yang; Changsheng Ma; Dong Zhao; Jing Liu; Yongchen Hao; Jun Liu; Na Yang; Hong Cheng
Journal:  BMC Nephrol       Date:  2022-01-13       Impact factor: 2.388

Review 2.  The American Heart Association's Get With the Guidelines (GWTG)-Stroke development and impact on stroke care.

Authors:  Cora H Ormseth; Kevin N Sheth; Jeffrey L Saver; Gregg C Fonarow; Lee H Schwamm
Journal:  Stroke Vasc Neurol       Date:  2017-05-29

3.  Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention.

Authors:  Toshiki Kuno; Yohei Numasawa; Mitsuaki Sawano; Toshiomi Katsuki; Masaki Kodaira; Ikuko Ueda; Masahiro Suzuki; Shigetaka Noma; Koji Negishi; Shiro Ishikawa; Hiroaki Miyata; Keiichi Fukuda; Shun Kohsaka
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

4.  Rationale and design of the improving Care for Cardiovascular Disease in China (CCC) project: a national registry to improve management of atrial fibrillation.

Authors:  Yongchen Hao; Jing Liu; Sidney C Smith; Yong Huo; Gregg C Fonarow; Junbo Ge; Jun Liu; Kathryn A Taubert; Louise Morgan; Yang Guo; Mengge Zhou; Dong Zhao; Changsheng Ma
Journal:  BMJ Open       Date:  2018-07-05       Impact factor: 2.692

5.  Short-term and long-term prognostic value of circulating soluble suppression of tumorigenicity-2 concentration in acute coronary syndrome: a meta-analysis.

Authors:  Linlin Gu; Jing Li
Journal:  Biosci Rep       Date:  2019-06-04       Impact factor: 3.840

6.  Protocol of the China ST-segment elevation myocardial infarction (STEMI) Care Project (CSCAP): a 10-year project to improve quality of care by building up a regional STEMI care network.

Authors:  Yan Zhang; Bo Yu; Yaling Han; Jianan Wang; Lixia Yang; Zheng Wan; Zheng Zhang; Yuguo Chen; Xianghua Fu; Chuanyu Gao; Bao Li; Jiyan Chen; Ming Wu; Yitong Ma; Xingsheng Zhao; Yundai Chen; Hongbing Yan; Dingcheng Xiang; Weiyi Fang; Sameer Mehta; Christoph K Naber; Junbo Ge; Yong Huo
Journal:  BMJ Open       Date:  2019-07-17       Impact factor: 2.692

7.  The association between atrial fibrillation and in-hospital outcomes in chronic kidney disease patients with acute coronary syndrome: findings from the improving care for cardiovascular disease in China-acute coronary syndrome (CCC-ACS) project.

Authors:  Lijiao Yang; Nan Ye; Guoqin Wang; Weijing Bian; Fengbo Xu; Dong Zhao; Jing Liu; Yongchen Hao; Jun Liu; Na Yang; Hong Cheng
Journal:  BMC Cardiovasc Disord       Date:  2021-07-17       Impact factor: 2.298

8.  In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.

Authors:  Guanqi Zhao; Mengge Zhou; Changsheng Ma; Yong Huo; Sidney C Smith; Gregg C Fonarow; Junbo Ge; Yaling Han; Jing Liu; Yongchen Hao; Jun Liu; Xiao Wang; Kathryn A Taubert; Louise Morgan; Dong Zhao; Shaoping Nie
Journal:  J Am Heart Assoc       Date:  2018-03-30       Impact factor: 5.501

9.  Prognostic indicators of new onset atrial fibrillation in patients with acute coronary syndrome.

Authors:  Hengliang Zhang; Pingshuan Dong; Xvming Yang; Laijing Du; Ke Wang; Peng Yan; Huifeng Zhang; Tengfei Wang; Xikun Zhao; Tengfei Guo
Journal:  Clin Cardiol       Date:  2020-04-14       Impact factor: 2.882

10.  Prevalence and in-hospital outcomes of diabetes among patients with acute coronary syndrome in China: findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project.

Authors:  Mengge Zhou; Jing Liu; Yongchen Hao; Jun Liu; Yong Huo; Sidney C Smith; Junbo Ge; Changsheng Ma; Yaling Han; Gregg C Fonarow; Kathryn A Taubert; Louise Morgan; Na Yang; Yueyan Xing; Dong Zhao
Journal:  Cardiovasc Diabetol       Date:  2018-11-27       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.